BACE1 and Alzheimer disease: In summary, besides the application in the patients with cerebral ischemic stroke [2], [31], [72], we have identified anti-stroke herbal medicine TLJN as a modulator of BACE1 and γ-secretase complex, which provides a mechanistic clue for the application in neurodegenerative diseases such as AD.